Emmanuel Zorn

Author PubWeight™ 13.66^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission.	Blood	2004	2.89
2	Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report.	Biol Blood Marrow Transplant	2006	1.86
3	Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.	Blood	2003	1.79
4	Graft-versus-tumor response in patients with multiple myeloma is associated with antibody response to BCMA, a plasma-cell membrane receptor.	Blood	2005	1.24
5	Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.	Transplantation	2010	1.10
6	Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.	Transplantation	2011	0.91
7	Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts.	Transpl Immunol	2012	0.84
8	Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis.	Blood	2006	0.84
9	Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.	Transplantation	2016	0.80
10	Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports.	Clin Transpl	2009	0.80
11	Expansion and somatic hypermutation of B-cell clones in rejected human kidney grafts.	Transplantation	2014	0.77
12	Dynamics of B cell recovery following kidney/bone marrow transplant recipients.	Transplantation	2017	0.75
13	Clinical relevance of soluble HLA class I molecules in Waldenstrom Macroglobulinemia.	Eur J Haematol	2008	0.75
14	New answers to old conundrums: what antibodies, exosomes and inflammasomes bring to the conversation. Canadian National Transplant Research Program international summit report.	Transplantation	2017	0.75